Read more about our company, our research, and partnerships.
Exploring the link between acute aerobic activity, brain function, and learning potential in regular and non-regular exercisers
BlinkLab is thrilled to share the successful outcome of its Pre-Submission meeting with the FDA, marking a critical step toward achieving 510(k) clearance for its innovative autism diagnostic app, BlinkLab Dx 1. With the study design and data requirements now confirmed, BlinkLab is poised to initiate a robust clinical program that will pave the way for regulatory approval and market entry in the US.
BlinkLab partners with Monash University for a two-year MAGNET project to enhance autism and ADHD diagnosis using app-based AI technology.
BlinkLab is thrilled to partner with Mental Care Group (MCG) to advance ADHD diagnosis through smartphone-based digital sensory phenotyping. By integrating BlinkLab’s innovative app into its diagnostic processes, MCG aims to enhance accuracy, efficiency, and accessibility in ADHD assessments, offering a transformative approach for patients and healthcare providers alike.
A major step we are proud to share!
BlinkLab closes seed round!
Princeton’s BlinkLab technology has earned support from the university’s IP Accelerator Fund to advance its development. This funding helps transform promising discoveries into market-ready innovations through prototyping and performance validation.
Princeton University’s BlinkLab technology, now patented, transforms neurobehavioral testing with a smartphone-based app for eyeblink conditioning. This breakthrough simplifies learning and memory research, eliminating the need for costly equipment.
Let's make developmental diagnostic evaluation more efficient and accessible.
And stay up to date with the latest developments of our product!
You will receive our newsletter. You can opt out via the newsletter.
